A Study Evaluating APG777 in Atopic Dermatitis

Clinical trial NCT06395948 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06395948
Sponsor: Apogee Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2024-04-29
Primary completion: 2026-11-01
Enrollment: 470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.